Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “air”

656 pharma patents match "air" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 656
Index total 30,257
Page 2 / 28

Quick answer

This filtered view shows 656 pharmaceutical patents matching "air" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

656 results for “air” · 30,257 patents in full index Clear search

  1. US 12337019

    Vehicles for applying bacteria to skin, scalp, and hair

    Northwestern University · Granted Jun 24, 2025 · Expires Jun 19, 2045

    granted
  2. US 12336974

    Methods and compositions for preventing and treating auditory dysfunctions

    United States Government as represented by the Department of Veterans Affairs · Granted Jun 24, 2025 · Expires Jun 19, 2045

    granted
  3. US 12329909

    Airway management systems for pulmonary disorder treatment

    Covidien LP · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  4. US 12331105

    Broadly neutralizing antibodies against HIV

    United States Government as represented by the Department of Veterans Affairs · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  5. US 12329827

    Devices, compositions and related methods for accelerating and enhancing bone repair

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  6. US 12329882

    Aligned hydrogel tubes for tissue repair and regeneration

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  7. US 12318362

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  8. US 12285478

    Foot-and-mouth disease vaccine

    United States of America as represented by the Secretary of the Air Force · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  9. US 12281060

    Remodilins for airway remodeling and organ fibrosis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  10. US 12274723

    Bacteriophage compositions and methods for treatment of bacterial infections

    United States Government as represented by the Department of Veterans Affairs · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  11. US 12269803

    Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease

    United States Government as represented by the Department of Veterans Affairs · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  12. WO 2025062334

    DÉRIVÉS DE 4-((5-(3-(4-(PYRIDIN-2-YL)CYCLOPENTYL)-1 H-PYRAZOL-3-YL)AMINO)-BENZÈNESULFONAMIDE ET COMPOSÉS SIMILAIRES UTILISÉS COMME INHIBITEURS DE CDK POUR LE TRAITEMENT DU CANCER

    BEIGENE SWITZERLAND GMBH [CH] · Granted Mar 27, 2025 · Expires Mar 22, 2045

    granted
  13. WO 2025052303

    ARN CIRCULAIRE ET PROCÉDÉS DE PRÉPARATION ASSOCIÉS

    BEIGENE SWITZERLAND GMBH [CH] · Granted Mar 13, 2025 · Expires Mar 8, 2045

    granted
  14. US 12246012

    Method for treating nervous system injuries using boldine and derivatives thereof

    United States Government as represented by the Department of Veterans Affairs · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  15. US 12233087

    Palladium hyaluronic acid particles and methods of managing cancer or angiogenic conditions

    The United States Government represented byt The United States Department of Veterans Affairs · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  16. US 12227503

    Compositions and methods for modulating hair growth

    The Regents of the University of California · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  17. US 12226423

    Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide

    United States Government as represented by the Department of Veterans Affairs · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  18. US 12227479

    Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury

    United States Government as represented by the Department of Veterans Affairs · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  19. US 12214014

    Methods for scar reduction by converting scar fibroblasts into adipocytes with hair follicle-derived signals

    The Regents of the University of California · Granted Feb 4, 2025 · Expires Jan 30, 2045

    granted
  20. US 12215108

    Development of potential antidotes for arsenicals

    United States Government as represented by the Department of Veterans Affairs · Granted Feb 4, 2025 · Expires Jan 30, 2045

    granted
  21. US 12208092

    Compositions and methods for administering paltusotine to patients with hepatic impairment

    CRINETICS PHARMACEUTICALS, INC. · Granted Jan 28, 2025 · Expires Jan 23, 2045

    granted
  22. US 12201699

    Compositions and methods for promoting homology directed repair

    Editas Medicine, Inc. · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  23. US 12194016

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  24. US 12178626

    Encapsulated gas or partial vacuum CT contrast material

    United States Government as represented by the Department of Veterans Affairs · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted